PubRank

L Boumsell

Author PubWeight™ 101.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J Clin Invest 1993 1.80
2 Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci U S A 1996 1.80
3 Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur J Immunol 1978 1.58
4 T cell activation via CD2 [T, gp50] molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11(1) epitopes. J Immunol 1985 1.58
5 An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution on normal and malignant lymphoid cells. J Exp Med 1980 1.50
6 Phenomenon of human T cells rosetting with sheep erythrocytes analyzed with monoclonal antibodies. "Modulation" of a partially hidden epitope determining the conditions of interaction between T cells and erythrocytes. J Exp Med 1982 1.48
7 Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J Immunol 2001 1.42
8 Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J Immunol 1992 1.40
9 Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis. J Immunol 2001 1.38
10 Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group. Lancet 1999 1.35
11 Heterogeneity of the first cluster of differentiation: characterization and epitopic mapping of three CD1 molecules on normal human thymus cells. J Immunol 1986 1.32
12 Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases. Am J Pathol 1991 1.22
13 A 19-kDa human erythrocyte molecule H19 is involved in rosettes, present on nucleated cells, and required for T cell activation. Comparison of the roles of H19 and LFA-3 molecules in T cell activation. J Immunol 1989 1.20
14 T cell activation via CD2 [T, gp50]: the role of accessory cells in activating resting T cells via CD2. J Immunol 1986 1.19
15 A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity. J Exp Med 1993 1.11
16 The human cell surface glycoprotein complex (gp 120,200) recognized by monoclonal antibody K20 is a component binding to phytohaemagglutinin on T cells. Scand J Immunol 1986 1.10
17 Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol 1998 1.09
18 Human T cell differentiation antigens and correlation of their expression with various markers of T cell maturation. J Immunol 1979 1.06
19 Monocyte-derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules. J Leukoc Biol 1998 1.05
20 CD100 is associated with CD45 at the surface of human T lymphocytes. Role in T cell homotypic adhesion. J Immunol 1996 1.04
21 Enhancement of T-lymphocyte differentiation in vitro by thymic extracts after bone marrow transplantation in severe combined immunodeficiencies. Clin Immunol Immunopathol 1975 1.04
22 Subsets of malignant lymphomas in children related to the cell phenotype. Blood 1979 1.03
23 Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma. Blood 1998 1.02
24 Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro. J Virol 1994 1.01
25 Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood 1981 1.01
26 Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg). Clin Exp Immunol 1993 1.01
27 Activation signals are delivered through two distinct epitopes of CD100, a unique 150 kDa human lymphocyte surface structure previously defined by BB18 mAb. Int Immunol 1995 1.00
28 Langerhans' cell histiocytosis. Definitive diagnosis with the use of monoclonal antibody O10 on routinely paraffin-embedded samples. Am J Surg Pathol 1995 1.00
29 Triggering CD101 molecule on human cutaneous dendritic cells inhibits T cell proliferation via IL-10 production. Eur J Immunol 2000 0.99
30 Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor. Blood 1982 0.98
31 Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J Immunol 1999 0.98
32 CD100 is a leukocyte semaphorin. Cell Mol Life Sci 1998 0.97
33 Mouse mononuclear cell chemotaxis. I. Differential response of monocytes and macrophages. J Immunol 1975 0.96
34 Anti-D47: a monoclonal antibody reacting with the secretory cells of human eccrine sweat glands. Br J Dermatol 1983 0.96
35 Immunohistochemical detection of CD1A antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody 010. J Pathol 1993 0.95
36 The human semaphorin-like leukocyte cell surface molecule CD100 associates with a serine kinase activity. J Biol Chem 1997 0.95
37 Lymphocytes subsets in normal individuals: analysis by four color immunofluorescence and flow cytometry on whole blood. Tissue Antigens 1996 0.94
38 The clusters of differentiation (CD) defined by the First International Workshop on Human Leucocyte Differentiation Antigens. Hum Immunol 1984 0.94
39 Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis. J Invest Dermatol 2000 0.94
40 Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cells. Blood 1981 0.93
41 A unique epitope on the CD2 molecule defined by the monoclonal antibody 9-1: epitope-specific modulation of the E-rosette receptor and effects on T-cell functions. Hum Immunol 1986 0.93
42 The CD39 molecule defines distinct cytotoxic subsets within alloactivated human CD8-positive cells. Eur J Immunol 1992 0.93
43 The sheep erythrocyte receptor and both alpha and beta chains of the human T-lymphocyte antigen receptor bind the mitogenic lectin (phytohaemagglutinin) from Phaseolus vulgaris. Scand J Immunol 1986 0.92
44 The lymphocyte surface antigen CD38 acts as a nicotinamide adenine dinucleotide glycohydrolase in human T lymphocytes. Eur J Immunol 1993 0.92
45 Erythrodermic cutaneous T-cell lymphoma with disseminated pustulosis. Production of high levels of interleukin-8 by tumour cells. Br J Dermatol 2001 0.90
46 CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. Blood 2001 0.90
47 BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity. Proc Natl Acad Sci U S A 1994 0.90
48 Tyrosine phosphorylation and association with phospholipase C gamma-1 of the GAP-associated 62-kD protein after CD2 stimulation of Jurkat T cell. J Exp Med 1993 0.90
49 Role in T-cell activation for HLA class I molecules from accessory cells: further distinction between activation signals delivered to T cells via CD2 and CD3 molecules. Proc Natl Acad Sci U S A 1987 0.90
50 Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol 2000 0.88
51 HLA class I molecules are associated with CD1a heavy chains on normal human thymus cells. Proc Natl Acad Sci U S A 1988 0.87
52 [Identification of lymphocyte populations producing alpha-interferon by monoclonal antibodies]. C R Seances Acad Sci III 1982 0.87
53 Enhancement of T lymphocyte differentiation in vitro by thymic extracts and purified polypeptides in severe combined immunodeficiency diseases. Trans Assoc Am Physicians 1975 0.86
54 Proliferation of resting lymphocytes is induced by triggering T cells through an epitope common to the three CD18/CD11 leukocyte adhesion molecules. Cell Immunol 1991 0.86
55 Do primary cutaneous non-T non-B CD4+CD56+ lymphomas belong to the myelo-monocytic lineage? J Invest Dermatol 1998 0.86
56 [The value of good Biozzi antibody-producing strains of mice for the production of monoclonal antibodies]. C R Seances Acad Sci D 1979 0.86
57 In vivo association of CD5 with tyrosine-phosphorylated ZAP-70 and p21 phospho-zeta molecules in human CD3+ thymocytes. J Immunol 1997 0.85
58 TCR gamma delta bearing T lymphocytes infiltrating human primary cutaneous melanomas. J Invest Dermatol 1992 0.85
59 Switch in the protein tyrosine phosphatase associated with human CD100 semaphorin at terminal B-cell differentiation stage. Blood 2000 0.85
60 Complement inhibitor(s) released by leukocytes. III. Evidence for a "new" C1 inhibitor in the supernatants of short-term cultures of mouse spleen and thymus cells. J Immunol 1975 0.84
61 Correspondence between lectin-defined and surface antigen-defined cell subpopulations in the human thymus: its variation during ontogeny. J Immunol 1981 0.84
62 Three different erythrocyte surface molecules are required for spontaneous T cell rosette formation. J Immunol 1987 0.83
63 Correlation between T cell receptor gamma delta isotypic forms and cytotoxic activity: analysis with human T cell clones and lines. Cell Immunol 1990 0.83
64 Analysis of junctional diversity in the preferential V delta 1-J delta 1 rearrangement of fresh T-acute lymphoblastic leukemia cells by in vitro gene amplification and direct sequencing. Blood 1989 0.83
65 A novel human leukocyte differentiation antigen: monoclonal antibody anti-D44 defines a 28 Kd molecule present on immature hematologic cells and a subpopulation of mature T cells. J Immunol 1984 0.83
66 Phenotypic characterization of the thymus microenvironment study of the human thymus architecture. Thymus 1986 0.83
67 Significant enlargement of a specific subset of CD3+CD8+ peripheral blood leukocytes mediating cytotoxic T-lymphocyte activity during human immunodeficiency virus infection. Proc Natl Acad Sci U S A 1993 0.83
68 Analysis of CD1 molecules on thymus cells and leukemic T lymphoblasts identifies discrete phenotypes and reveals that CD1 intermolecular complexes are observed only on normal cells. Blood 1987 0.82
69 The heterogeneity and functional capacities of human thymocyte subpopulations. Proc Natl Acad Sci U S A 1984 0.82
70 Poor lymphocyte recovery following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Br J Haematol 1999 0.81
71 Intermolecular complexes between three human CD1 molecules on normal thymus cells. Immunogenetics 1988 0.81
72 CD1 stimulation of human T cell lines induces a rapid increase in the intracellular free Ca2+ concentration and the production of IL-2. J Immunol 1990 0.81
73 CD antigens 1993. Blood 1994 0.81
74 Increased expression of a novel early activation surface membrane receptor in cutaneous T cell lymphoma cells. J Invest Dermatol 2001 0.81
75 Infiltrating lymphocytes in benign and malignant naevomelanocytic lesions. Nouv Rev Fr Hematol 1990 0.81
76 Regulation of immunoglobulin synthesis by human T cell subsets as defined by anti-D44 monoclonal antibody within the CD4+ and CD8+ subpopulations. J Immunol 1986 0.80
77 CD antigens 1993. J Immunol 1994 0.80
78 Identification of a novel 110-kilodalton structure expressed on a subset of T cell receptor-gamma delta-bearing cloned lymphocytes. J Immunol 1990 0.80
79 Functional role of PECAM-1/CD31 molecule expressed on human cord blood progenitors. Leukemia 1996 0.80
80 A T cell surface molecule different from CD2 is involved in spontaneous rosette formation with erythrocytes. J Immunol 1988 0.80
81 Study of the CD3-associated T-cell receptors reveals further differences between T-cell acute lymphoblastic lymphoma and leukemia. Blood 1990 0.80
82 Syndrome of neutrophil agranulocytosis, hypogammaglobulinemia, and thymoma. Blood 1982 0.80
83 Functional characterization of neurotensin receptors in human cutaneous T cell lymphoma malignant lymphocytes. J Invest Dermatol 2001 0.80
84 Probing human malignant T cells with lectins: a comparison with their surface antigen patterns defined by monoclonal antibodies. Leuk Res 1982 0.80
85 High efficiency of Biozzi's high responder mouse strain in the generation of antibody secreting hybridomas. J Immunol Methods 1980 0.79
86 Immunodeficiency after bone marrow transplantation can be associated with autoreactive T-cell receptor gamma delta-bearing lymphocytes. Immunol Rev 1990 0.79
87 CD101 is expressed by skin dendritic cells. Role in T-lymphocyte activation. Tissue Antigens 1997 0.79
88 Serological expression after sequential double transfection with purified HLA-A11 gene of mouse fibroblasts carrying human beta-2 microglobulin. Immunogenetics 1985 0.79
89 The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets. Eur J Immunol 1988 0.78
90 Identification of cell surface molecules characterizing human cutaneous T-cell lymphomas. Leuk Lymphoma 2002 0.78
91 K20 and ICO-10 monoclonal antibodies (gp120/200; Thy-1): immunophenotyping of human solid tumours. Br J Cancer 1990 0.78
92 CD antigens 1993. Immunol Today 1994 0.78
93 CD101 expression by Langerhans cell histiocytosis cells. Histopathology 2000 0.78
94 Potential antileukemic effect of gamma delta T cells in acute lymphoblastic leukemia. Leukemia 1995 0.78
95 Control of cell proliferation within the human thymus. A very limited thymocyte subpopulation generates a suppressive activity. Eur J Immunol 1986 0.78
96 Hand-mirror cells in T-cell lymphoma. Lancet 1978 0.77
97 Comparison of signals delivered through CD3 and CD2 for T-cell activation: the role of calcium influx and interleukin 1. Hum Immunol 1988 0.77
98 Functional characterization of an IL-7-dependent CD4(+)CD8alphaalpha(+) Th3-type malignant cell line derived from a patient with a cutaneous T-cell lymphoma. Blood 2000 0.77
99 Functional inhibitory receptors expressed by a cutaneous T cell lymphoma-specific cytolytic clonal T cell population. J Invest Dermatol 2000 0.77
100 Selective induction of autocytotoxic activity through the CD3 molecule. Eur J Immunol 1990 0.77
101 A surface glycoprotein complex related to the adhesive receptors of the VLA family, shared by epidermal Langerhans cells and basal keratinocytes. J Invest Dermatol 1989 0.77
102 Regulation of helper T cell clone proliferation via the CD2 molecule. Cell Immunol 1987 0.77
103 Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas. Ann N Y Acad Sci 2001 0.77
104 Cleavage of Langerhans cell surface CD1a molecule by trypsin. Res Immunol 1989 0.76
105 Detection of membrane-bound HLA-G translated products with a specific monoclonal antibody. Proc Natl Acad Sci U S A 1995 0.76
106 Differential proliferative responses in subsets of human CD28+ cells delineated by BB27 mAb. Int Immunol 1994 0.76
107 The correlation of adenosine deaminase and purine nucleoside phosphorylase activities in human lymphocytes subpopulations and in various lymphoid malignancies. Leuk Res 1982 0.76
108 Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue. Int Immunol 2001 0.76
109 [Anomalies of the immune system in chronic inflammatory bowel diseases]. Gastroenterol Clin Biol 1994 0.75
110 The receptors regulating natural cytotoxic effector functions. Arch Immunol Ther Exp (Warsz) 2001 0.75
111 [Differentiation antigens of malignant leukocytes (2)]. Presse Med 1984 0.75
112 [Contribution of immunotherapy to the treatment of T-cell lymphoma of the skin]. Presse Med 1999 0.75
113 [ICO-35 monoclonal antibodies to the antigen of acute lymphoblastic leukemia]. Eksp Onkol 1989 0.75
114 Delineation of human cord blood hematopoietic progenitor cell subsets with a unique monoclonal antibody AY19. Tissue Antigens 1998 0.75
115 CD1 expression on B-CLL lymphocytes. Br J Haematol 1989 0.75
116 Leukocyte-derived complement inhibitor. IV. The functional properties of C1 bound to erythrocytes pretreated with leukocyte culture supernatant. J Immunol 1976 0.75
117 Interleukin-13 responsiveness and interleukin-13 receptor expression in non-Hodgkin's lymphoma and reactive lymph node B cells. Modulation by CD40 activation. Eur Cytokine Netw 1997 0.75
118 [Value of immunological investigations in a difficult diagnosis of acute lymphoblastic leukaemia (author's transl)]. Nouv Presse Med 1981 0.75
119 [Fall in the levels of circulating lymphoblasts caused by intravenous administration of the A50 monoclonal antibody in a patient with acute T-cell lymphoblastic leukemia. A step in the demonstration of serotherapy with monoclonal antibodies]. Nouv Presse Med 1982 0.75
120 Identification of a novel functional 85-kD glycoprotein restricted to long-term dividing human lymphocytic lines. Hum Immunol 1993 0.75
121 Leukemia versus lymphoma in children: a worthless question? Med Pediatr Oncol 1986 0.75
122 [Implication of HLA class I molecule from monocyte in T-cell activation by CD2 or CD3 monoclonal antibodies]. C R Acad Sci III 1987 0.75
123 Isolation of a CD8alphaalpha+ CD4- tumour T-cell clone with cytotoxic activity from a CD4+ CD8- cutaneous T-cell lymphoma. Br J Dermatol 2003 0.75
124 Preferential elimination of NK and CTL functions by anti-D44 monoclonal antibody. J Immunol 1984 0.75
125 T lymphocyte differentiation in vitro in ataxia telangiectasia associated with lymphosarcoma. J Pediatr 1975 0.75
126 Functional role of CD101 on skin dendritic cells. Adv Exp Med Biol 1997 0.75
127 CD4+ CD56+ blastic tumor cells express CD101 molecules. J Invest Dermatol 2005 0.75
128 [Human leukocyte differentiation antigens]. Presse Med 1984 0.75
129 Complement inhibitor(s) released from leukocytes. II. Evidence that lymphocytes release and produce an inhibitor of C2 activation. Cell Immunol 1976 0.75
130 [Monoclonal antibodies and flow microfluorometry. Decisive progress in the study of markers of normal and cancer cells]. Arch Fr Pediatr 1981 0.75
131 Activation of T-cells through an antigen-independent alternative pathway induces precocious sensitivity to Fas-induced apoptosis. Immunol Lett 1997 0.75
132 Enhanced CD3 monoclonal antibody induced proliferation of colonic mucosal T lymphocytes in Crohn's disease patients free of corticosteroid or immunosuppressor treatment. Clin Immunol Immunopathol 1996 0.75
133 Utilization of two different T cell receptors by T cell acute lymphoblastic lymphoma and leukemia. Nouv Rev Fr Hematol 1990 0.75
134 CD1 expression in B-CLL cells. Nouv Rev Fr Hematol 1988 0.75
135 [Burkitt's type acute lymphoblastic leukemia. Cellular phenotype and chromosome abnormally (author's transl)]. Arch Fr Pediatr 1981 0.75
136 Immunologic analysis of a thousand cases of acute leukemia. French Groupe d'Etude Immunologique des Leucémies (GEIL). Nouv Rev Fr Hematol 1989 0.75
137 G10.3 monoclonal antibody identifies novel functional cell surface structures expressed by normal B lymphocytes and various malignant cell lines. Tissue Antigens 1999 0.75
138 [Search for antilymphocytic antibodies in the serum of 67 children with juvenile chronic arthritis]. Rev Rhum Mal Osteoartic 1980 0.75
139 Changes in surface antigens on malignant T cells from lymphoblastic lymphomas at relapse: an appraisal with monoclonal antibodies and microfluorometry. Blood 1982 0.75
140 Complement inhibitor(s) released by leukocytes. I. Pretreatment of sheep erythrocytes with supernatants of mouse spleen and thymus cells inhibit whole complement activity and C2 utilization. J Immunol 1975 0.75